Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Harsimran Kaur, Garcha"'
Autor:
Harsimran Kaur Garcha, Nabanita Nawar, Helena Sorger, Fettah Erdogan, Myint Myat Khine Aung, Abootaleb Sedighi, Pimyupa Manaswiyoungkul, Hyuk-Soo Seo, Susann Schönefeldt, Daniel Pölöske, Sirano Dhe-Paganon, Heidi A. Neubauer, Satu M. Mustjoki, Marco Herling, Elvin D. de Araujo, Richard Moriggl, Patrick T. Gunning
Publikováno v:
Pharmaceuticals, Vol 15, Iss 11, p 1321 (2022)
NK/T-cell lymphoma (NKTCL) and γδ T-cell non-Hodgkin lymphomas (γδ T-NHL) are highly aggressive lymphomas that lack rationally designed therapies and rely on repurposed chemotherapeutics from other hematological cancers. Histone deacetylases (HDA
Externí odkaz:
https://doaj.org/article/87a893d2ff80432881eea8c588541e56
Autor:
Nabanita Nawar, Shazreh Bukhari, Ashley A. Adile, Yujin Suk, Pimyupa Manaswiyoungkul, Krimo Toutah, Olasunkanmi O. Olaoye, Yasir S. Raouf, Abootaleb Sedighi, Harsimran Kaur Garcha, Muhammad Murtaza Hassan, William Gwynne, Johan Israelian, Tudor B. Radu, Mulu Geletu, Ayah Abdeldayem, Justyna M. Gawel, Aaron D. Cabral, Chitra Venugopal, Elvin D. de Araujo, Sheila K. Singh, Patrick T. Gunning
Publikováno v:
Journal of Medicinal Chemistry. 65:3193-3217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc016ee3578a633ee7c466b4bdc32cac
https://doi.org/10.1021/acs.jmedchem.1c01585
https://doi.org/10.1021/acs.jmedchem.1c01585
Autor:
Nabanita Nawar, Harsimran Kaur Garcha, Abootaleb Sedighi, Elvin D. de Araujo, Patrick T. Gunning
Publikováno v:
Methods in Molecular Biology ISBN: 9781071627877
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f3ab7279e261671340d8f74fab69a13
https://doi.org/10.1007/978-1-0716-2788-4_11
https://doi.org/10.1007/978-1-0716-2788-4_11
Autor:
Nabanita, Nawar, Harsimran Kaur, Garcha, Abootaleb, Sedighi, Elvin D, de Araujo, Patrick T, Gunning
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2589
The aberrant activity of histone deacetylases (HDACs) across a broad range of cancers and other disease indications has led to the development of small-molecule inhibitors that target one or more members of the HDAC protein family. Emerging HDAC inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb39fbbc58dac644e36b47dedd0ae6de
https://pubmed.ncbi.nlm.nih.gov/36255624
https://pubmed.ncbi.nlm.nih.gov/36255624